$23.55
-0.13[-0.55%]
Last update: 4:25PM Get Real Time Here
Rocket Pharmaceuticals
(NASDAQ:RCKT)Latest News for Rocket Pharmaceuticals Stock (NASDAQ:RCKT)
Rocket Pharmaceuticals Stock (NASDAQ: RCKT)
Categories: All
Wednesday, April 10, 2024
Tuesday, April 02, 2024
- Goldman Sachs Initiates Coverage On Rocket Pharmaceuticals with Neutral Rating, Announces Price Target of $39Benzinga Newsdesk - Apr 2, 2024, 7:07AM
- The European Medicines Agency Accepted The Marketing Authorization Application For Rocket Pharmaceuticals' RP-l102 For Fanconi AnemiaBenzinga Newsdesk - Apr 2, 2024, 6:04AM
Tuesday, March 26, 2024
Friday, March 01, 2024
Tuesday, February 27, 2024
Monday, February 26, 2024
Tuesday, February 13, 2024
- Needham Reiterates Buy on Rocket Pharmaceuticals, Maintains $53 Price TargetBenzinga Newsdesk - Feb 13, 2024, 11:46AM
- Rocket Pharmaceuticals Announced The FDA Has Extended The Priority Review Period For Kresladi Application For Severe Leukocyte Adhesion Deficiency-I, By Three Months To June 30, 2024Benzinga Newsdesk - Feb 13, 2024, 7:27AM
Wednesday, January 31, 2024
Tuesday, December 05, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
Tuesday, October 24, 2023
Friday, September 15, 2023
Wednesday, September 13, 2023
- Dow Turns Lower; KULR Technology Group Shares PlummetLisa Levin - Sep 13, 2023, 3:05PM
- Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Sep 13, 2023, 2:07PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Sep 13, 2023, 1:31PM
- US Stocks Rise Despite Hot Inflation As Fed Sentiment Remains Unshaken: What's Driving Markets Wednesday?Shanthi Rexaline - Sep 13, 2023, 1:13PM
- Dow Gains 50 Points; US Crude Oil Inventories RiseLisa Levin - Sep 13, 2023, 12:01PM
- Stifel Reiterates Buy on Rocket Pharmaceuticals, Maintains $48 Price TargetBenzinga Newsdesk - Sep 13, 2023, 10:39AM
- What's Going On With Gene Therapy-Focused Rocket Pharmaceuticals Stock Today?Vandana Singh - Sep 13, 2023, 10:23AM
- Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On WednesdayLisa Levin - Sep 13, 2023, 10:13AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Sep 13, 2023, 9:06AM
- GoDaddy To Rally Around 44%? Here Are 10 Other Analyst Forecasts For WednesdayLisa Levin - Sep 13, 2023, 8:45AM
- Rocket Pharmaceuticals shares are trading higher after the company announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501 for Danon Disease.Benzinga Newsdesk - Sep 13, 2023, 8:17AM
- Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving PremarketLisa Levin - Sep 13, 2023, 8:16AM
- Analyst Expectations for Rocket Pharmaceuticals's FutureBenzinga Insights - Sep 13, 2023, 8:01AM
- Needham Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $53Benzinga Newsdesk - Sep 13, 2023, 6:24AM
- Rocket Pharmaceuticals Prices $175M Public Offering Of 7,812,500 Common Shares At $16/Share, And Pre-Funded Warrants To Purchase 3,126,955 Common Shares At $15.99/Pre-Funded WarrantBenzinga Newsdesk - Sep 13, 2023, 2:36AM
Tuesday, September 12, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Sep 12, 2023, 5:31PM
- Rocket Pharmaceuticals shares are trading higher after the company announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501 for Danon Disease.Benzinga Newsdesk - Sep 12, 2023, 4:15PM
- Rocket Pharmaceuticals Announces Proposed Public Offering Of ~$150M Of Common Stock OfBenzinga Newsdesk - Sep 12, 2023, 4:02PM
- Rocket Pharmaceuticals Reaches FDA Alignment On Pivotal Phase 2 Trial Design For RP-A501 In Danon DiseaseBenzinga Newsdesk - Sep 12, 2023, 4:02PM
Friday, August 11, 2023
- What 5 Analyst Ratings Have To Say About Rocket PharmaceuticalsBenzinga Insights - Aug 11, 2023, 10:00AM
- Canaccord Genuity Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $47Benzinga Newsdesk - Aug 11, 2023, 8:18AM
- Chardan Capital Reiterates Buy on Rocket Pharmaceuticals, Maintains $61 Price TargetBenzinga Newsdesk - Aug 11, 2023, 4:20AM
Thursday, August 10, 2023
- Needham Reiterates Buy on Rocket Pharmaceuticals, Maintains $60 Price TargetBenzinga Newsdesk - Aug 10, 2023, 11:55AM
- Stifel Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $48Benzinga Newsdesk - Aug 10, 2023, 8:57AM
- Rocket Pharmaceuticals Q2 EPS $(0.82) Misses $(0.79) Estimate; Cash, Cash Equivalents And Investments Of Approximately $307M; Expected Operational Runway Into 1H 2025Benzinga Newsdesk - Aug 10, 2023, 7:09AM
Thursday, August 03, 2023
- Rocket Pharmaceuticals CEO Gaurav Shah At Benzinga's Biotech Conference Says Danon Would Be First Cardiac Gene TherapyBenzinga Newsdesk - Aug 3, 2023, 11:18AM
- Rocket Pharmaceuticals CEO Gaurav Shah At Benzinga's Biotech Conference Says Co. Has Its Own Manufacturing So Can Pivot QuicklyBenzinga Newsdesk - Aug 3, 2023, 11:17AM
- Rocket Pharmaceuticals CEO Gaurav Shah Says We Are Always Interested In Long-Term Value Creation; Says We Have Developed 4 Therapies, All Of Which Have Demonstrated Clinical Proof Of Concept And Is Developing More After TheseBenzinga Newsdesk - Aug 3, 2023, 11:15AM